vimarsana.com
Home
Live Updates
EQS-News: Heidelberg Pharma AG: Interim Management Statement
EQS-News: Heidelberg Pharma AG: Interim Management Statement
EQS-News: Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2022
EQS-News: Heidelberg Pharma AG / Key word(s): Quarterly / Interim Statement Heidelberg Pharma AG: Interim Management Statement on the...
Related Keywords
Redhill ,
New York ,
United States ,
Walldorf ,
Hessen ,
Germany ,
Australia ,
Memorial Sloan Kettering Cancer Center ,
Japan ,
Tokyo ,
China ,
Melbourne ,
Victoria ,
Canada ,
Mannheim ,
Baden Wüberg ,
Hangzhou ,
Zhejiang ,
Cambridge ,
Cambridgeshire ,
United Kingdom ,
Huadong ,
Guangdong ,
Turkey ,
Chinese ,
German ,
American ,
Heidelberg Pharmas Amanitin ,
Jan Schmidt ,
Chiome Bioscience ,
Heidelberg Pharma ,
Register Of The Mannheim Local Court ,
Telix Pharmaceuticals ,
China Grand Pharmaceutical ,
Heidelberg Pharma Group ,
Nasdaq ,
American Association For Cancer Research ,
Gmbh Co ,
Huadong Medicine Co Ltd ,
Chiome Bioscience Inc ,
German Federal Financial Supervisory Authority ,
Heidelberg Pharma Research ,
Heidelberg Pharma Research Gmb ,
Interim Management Statement ,
First Nine Months ,
Huadong Medicine ,
Antibody Targeted Amanitin Conjugate ,
Jan Schmidt Brand ,
American Association ,
Cancer Research ,
Magenta Therapeutics ,
Telix Pharmaceuticals Limited ,
China Grand Pharmaceutical Limited ,
Investigational New Drug ,
Redhill Biopharma ,
Commercial Register ,
Mannheim Local Court ,
Authorized Capital ,
Annual General Meeting ,
Heidelberg Pharma Research Gmbh ,